Revealed: Fauci Knew COVID Was Human-Adapted by February 2020

In a revelation that casts doubt on official narratives about COVID-19’s origins, recently released messages show that Dr. Anthony Fauci, former Director of the National Institute for Allergy and Infectious Diseases (NIAID), knew as early as February 2020 that the virus was highly adapted to human transmission. These communications, obtained by the House Select Subcommittee on the Coronavirus Pandemic, reveal Fauci was informed by then-China CDC head George Gao of the virus’s human-adaptive traits during the pandemic’s initial phase.

The exchange, conducted through WeChat, highlights that both U.S. and Chinese officials were aware of the virus’s unique characteristics early on. Gao’s observations were significant, as they suggested the virus might not have originated at the Huanan Seafood Wholesale Market, as initially claimed. Yet, despite this knowledge, Fauci and other public health officials consistently downplayed theories that the virus could have emerged from gain-of-function research and a subsequent escape from the Wuhan Institute of Virology.

The subcommittee’s report sheds light on how this crucial information came to light. Ping Chen, Fauci’s Beijing-based representative, relayed the conversation with Gao, noting his remark about the virus’s adaptation to humans. However, this key piece of information was not disclosed to the public until months later, when molecular biologist Alina Chan brought attention to the possibility of a laboratory origin.

In May 2020, a preprint suggested that SARS-CoV-2 might have either circulated undetected in humans or been adapted in a laboratory setting through serial passage—an experimental technique used to enhance a virus’s infectivity in specific hosts. This theory sparked intense debate but was largely dismissed by mainstream media and public health authorities, who favored a narrative of natural zoonotic evolution.

Notably, some scientists privately questioned the prevailing narrative. Among them were authors of a March 2020 Nature Medicine paper, which publicly argued against a lab origin. Private messages later revealed that these authors, including virologist Eddie Holmes, were aware of the virus’s unusual adaptation to humans and expressed doubts about their own conclusions.

Dr. Fauci’s handling of the information has drawn sharp criticism. While privately aware of the virus’s human-adaptive traits, he publicly championed the idea that SARS-CoV-2 likely evolved naturally. Fauci’s skepticism of a lab-origin theory aligned with efforts by public health authorities, media outlets, and even social media platforms to discredit such discussions as conspiracy theories.

Molecular biologist Alina Chan, who publicly questioned the natural origin theory, became a target of criticism from Fauci and other officials. Yet her arguments, supported by emerging evidence, reignited the debate over COVID-19’s origins and brought renewed attention to the role of gain-of-function research in Wuhan.

Fauci has repeatedly denied that NIAID funded gain-of-function research at the Wuhan Institute of Virology. However, critics argue that the dismissal of alternative theories, combined with the suppression of scientific dissent, undermined public trust in pandemic narratives.

The WeChat messages between Fauci’s representative and Gao provide a timeline of knowledge that contrasts sharply with the public narrative. Gao’s acknowledgment of the virus’s human adaptation raises questions about why this information was not disclosed sooner. It also challenges the validity of claims tying the outbreak exclusively to the Huanan Seafood Market.

The delay in addressing the virus’s peculiar features allowed the natural-origin theory to dominate public discourse. By the time questions about a possible lab origin gained traction, critical opportunities to investigate Wuhan’s laboratories and early outbreak data had been lost. This gap fueled speculation that officials were more concerned with protecting reputations than uncovering the truth.

The debate over SARS-CoV-2’s origins reached a boiling point in mid-2021, when intelligence agencies began exploring the lab-leak hypothesis. By then, much of the early evidence had either been destroyed or rendered inaccessible by Chinese authorities. The lack of transparency compounded frustrations among scientists who believed the lab-leak theory warranted serious investigation.

Criticism of Fauci’s role grew louder as additional documents, including grant applications and internal communications, surfaced. These materials suggested that U.S. agencies had, in fact, funded research in Wuhan that could qualify as gain-of-function. Fauci and others maintained that the research adhered to established safety protocols and did not involve enhancing a virus’s ability to infect humans.

The release of these WeChat messages underscores the challenges of maintaining transparency during a global crisis. Public trust in health authorities and scientific institutions has been eroded by revelations of withheld information and coordinated efforts to control the pandemic narrative.

Fauci’s critics argue that his handling of the situation exemplifies a broader problem of prioritizing institutional reputations over public accountability. Supporters counter that his focus was on preventing panic and ensuring a coordinated pandemic response. Regardless, the fallout has left a lasting impact on how the public perceives scientific and government officials.

The debate over COVID-19’s origins is far from settled. Investigators and independent researchers continue to push for access to Wuhan’s labs and early outbreak data, while political leaders demand accountability from both Chinese and U.S. officials. For Fauci, who retired in December 2022, these revelations may cast a long shadow over his decades-long career.

As new evidence emerges, the question remains: how much of the truth about COVID-19’s origins has yet to be uncovered, and at what cost was it obscured? For a world still grappling with the pandemic’s aftermath, the answers could reshape public trust in global health governance for years to come.